NBP261644
Histone H2AY/macroH2A.1 Antibody (CL5256), Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP261644-Each-of-1 | In Stock | ₹ 53,688.90 |
NBP261644 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 53,688.90
GST (18%): ₹ 9,664.002
Total Price: ₹ 63,352.902
Antigen
Histone H2AY/macroH2A.1
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
PBS, pH 7.2, containing 40% glycerol with 0.02% Sodium Azide
Gene Symbols
H2AFY
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: GEVSKAASADSTTEGTPA
Quantity
100 μL
Gene ID (Entrez)
9555
Target Species
Human
Form
Purified
Applications
Immunohistochemistry
Clone
CL5256
Dilution
Immunohistochemistry 1:200 - 1:500
Gene Alias
core histone macro-H2A.1, H2A histone family, member Y, H2A.y, H2A/y, H2AF12M, H2AFJ, Histone H2A.y, Histone macroH2A1, histone macroH2A1.1, histone macroH2A1.2, MACROH2A1, MACROH2A1.1, macroH2A1.2, Medulloblastoma antigen MU-MB-50.205, mH2A1
Host Species
Mouse
Purification Method
Protein A purified
Primary or Secondary
Primary
Test Specificity
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
Content And Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Isotype
IgG1
Related Products
Description
- Description Histone H2AY/macroH2A.1 Monoclonal specifically detects Histone H2AY/macroH2A.1 in Human samples
- It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.
Compare Similar Items
Show Difference
Antigen: Histone H2AY/macroH2A.1
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: PBS, pH 7.2, containing 40% glycerol with 0.02% Sodium Azide
Gene Symbols: H2AFY
Immunogen: This antibody was developed against a recombinant protein corresponding to amino acids: GEVSKAASADSTTEGTPA
Quantity: 100 μL
Gene ID (Entrez): 9555
Target Species: Human
Form: Purified
Applications: Immunohistochemistry
Clone: CL5256
Dilution: Immunohistochemistry 1:200 - 1:500
Gene Alias: core histone macro-H2A.1, H2A histone family, member Y, H2A.y, H2A/y, H2AF12M, H2AFJ, Histone H2A.y, Histone macroH2A1, histone macroH2A1.1, histone macroH2A1.2, MACROH2A1, MACROH2A1.1, macroH2A1.2, Medulloblastoma antigen MU-MB-50.205, mH2A1
Host Species: Mouse
Purification Method: Protein A purified
Primary or Secondary: Primary
Test Specificity: Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Isotype: IgG1
Antigen:
Histone H2AY/macroH2A.1
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
PBS, pH 7.2, containing 40% glycerol with 0.02% Sodium Azide
Gene Symbols:
H2AFY
Immunogen:
This antibody was developed against a recombinant protein corresponding to amino acids: GEVSKAASADSTTEGTPA
Quantity:
100 μL
Gene ID (Entrez):
9555
Target Species:
Human
Form:
Purified
Applications:
Immunohistochemistry
Clone:
CL5256
Dilution:
Immunohistochemistry 1:200 - 1:500
Gene Alias:
core histone macro-H2A.1, H2A histone family, member Y, H2A.y, H2A/y, H2AF12M, H2AFJ, Histone H2A.y, Histone macroH2A1, histone macroH2A1.1, histone macroH2A1.2, MACROH2A1, MACROH2A1.1, macroH2A1.2, Medulloblastoma antigen MU-MB-50.205, mH2A1
Host Species:
Mouse
Purification Method:
Protein A purified
Primary or Secondary:
Primary
Test Specificity:
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
Content And Storage:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Isotype:
IgG1
Antigen: CD19
Classification: Monoclonal
Conjugate: Alexa Fluor 488
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Gene Symbols: CD19
Immunogen: Recombinant full-length human CD19 protein (Uniprot: P15391 )
Quantity: 0.1 mL
Gene ID (Entrez): 930
Target Species: Human, Monkey
Form: __
Applications: Flow Cytometry, Immunocytochemistry, Immunofluorescence
Clone: CVID3/155
Dilution: Flow Cytometry, Immunocytochemistry/Immunofluorescence
Gene Alias: B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Host Species: Mouse
Purification Method: Protein A or G purified
Primary or Secondary: Primary
Test Specificity: Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Content And Storage: Store at 4°C in the dark.
Isotype: IgG1 κ
Antigen:
CD19
Classification:
Monoclonal
Conjugate:
Alexa Fluor 488
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Gene Symbols:
CD19
Immunogen:
Recombinant full-length human CD19 protein (Uniprot: P15391 )
Quantity:
0.1 mL
Gene ID (Entrez):
930
Target Species:
Human, Monkey
Form:
__
Applications:
Flow Cytometry, Immunocytochemistry, Immunofluorescence
Clone:
CVID3/155
Dilution:
Flow Cytometry, Immunocytochemistry/Immunofluorescence
Gene Alias:
B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Host Species:
Mouse
Purification Method:
Protein A or G purified
Primary or Secondary:
Primary
Test Specificity:
Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Content And Storage:
Store at 4°C in the dark.
Isotype:
IgG1 κ
Antigen: CD19
Classification: Monoclonal
Conjugate: APC
Formulation: PBS with 0.05% Sodium Azide
Gene Symbols: CD19
Immunogen: Recombinant full-length human CD19 protein (Uniprot: P15391 )
Quantity: 0.1 mL
Gene ID (Entrez): 930
Target Species: Human, Monkey
Form: __
Applications: Flow Cytometry
Clone: CVID3/155
Dilution: Flow Cytometry
Gene Alias: B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Host Species: Mouse
Purification Method: Protein A or G purified
Primary or Secondary: Primary
Test Specificity: Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Content And Storage: Store at 4°C in the dark.
Isotype: IgG1 κ
Antigen:
CD19
Classification:
Monoclonal
Conjugate:
APC
Formulation:
PBS with 0.05% Sodium Azide
Gene Symbols:
CD19
Immunogen:
Recombinant full-length human CD19 protein (Uniprot: P15391 )
Quantity:
0.1 mL
Gene ID (Entrez):
930
Target Species:
Human, Monkey
Form:
__
Applications:
Flow Cytometry
Clone:
CVID3/155
Dilution:
Flow Cytometry
Gene Alias:
B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Host Species:
Mouse
Purification Method:
Protein A or G purified
Primary or Secondary:
Primary
Test Specificity:
Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Content And Storage:
Store at 4°C in the dark.
Isotype:
IgG1 κ
Antigen: CD19
Classification: Monoclonal
Conjugate: DyLight 680
Formulation: PBS with 0.05% Sodium Azide
Gene Symbols: CD19
Immunogen: Recombinant full-length human CD19 protein (Uniprot: P15391 )
Quantity: 0.1 mL
Gene ID (Entrez): 930
Target Species: Human, Monkey
Form: __
Applications: Flow Cytometry, Immunocytochemistry, Immunofluorescence
Clone: CVID3/155
Dilution: Flow Cytometry, Immunocytochemistry/Immunofluorescence
Gene Alias: B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Host Species: Mouse
Purification Method: Protein A or G purified
Primary or Secondary: Primary
Test Specificity: Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Content And Storage: Store at 4°C in the dark.
Isotype: IgG1 κ
Antigen:
CD19
Classification:
Monoclonal
Conjugate:
DyLight 680
Formulation:
PBS with 0.05% Sodium Azide
Gene Symbols:
CD19
Immunogen:
Recombinant full-length human CD19 protein (Uniprot: P15391 )
Quantity:
0.1 mL
Gene ID (Entrez):
930
Target Species:
Human, Monkey
Form:
__
Applications:
Flow Cytometry, Immunocytochemistry, Immunofluorescence
Clone:
CVID3/155
Dilution:
Flow Cytometry, Immunocytochemistry/Immunofluorescence
Gene Alias:
B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
Host Species:
Mouse
Purification Method:
Protein A or G purified
Primary or Secondary:
Primary
Test Specificity:
Recognizes a protein of 95kDa, identified as CD19. CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Content And Storage:
Store at 4°C in the dark.
Isotype:
IgG1 κ